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Purpose 
To fabricate devices in micrometer size (microcontainers) in SU-8 by 
two-steps of photolithography, and to load these microcontainers with a 
powder of vaccine using an embossing method. Furthermore, this 
system was investigated as an oral delivery system for vaccines.  
 
Introduction  
Delivery of vaccine is often done by injection, but it would be much 
more convenient for the patients, if the vaccines could be dosed as a 
tablet via the oral route. For being able to deliver the vaccine by the oral 
route, a combination of an antigen, adjuvant and a particulate system is 
necessary. An example of such a particulate system is cubosomes. 
Cubosomes are highly twisted, continuous lipid bilayers with two 
congruent, non-intersecting water channels providing both hydrophilic 
and hydrophobic domains and a large surface area for associations of 
antigens and adjuvants [1].  
For delivering vaccines by the oral route, micro fabricated drug delivery 
devices can be used. Of these micro devices, microcontainers are 
suggested as especially promising [2], [3]. Primarily, this is due to the 
fact that the size and shape of the microcontainers can be controlled very 
precisely. Microcontainers are polymeric, cylindrical devices in the 
micrometer size range (Figs 1). A potential advantage of 
microcontainers is that these devices allow for unidirectional release, as 
only one side of the microcontainers is open compared to conventional 
particles where release occurs from the whole surface [2]. The 
microcontainers have been suggested as a potential approach to improve 
the oral bioavailability of drugs [4] as they are able to protect the drug or 
vaccine through the stomach and bring it to the intestine, where the drug 
or vaccine should be released and absorbed.  
 
Results 
The fabrication of microcontainers resulted in devices with an inner 
diameter of 220 µm and a cavity depth of 270 µm (Figs 1). A vaccine 
powder was produced by the method of spray drying, where a solution 
of lipid (Dimodan®), antigen (ovalbumin) and adjuvant (quil-A) in 
ethanol and water was sprayed into a powder. Subsequently, the powder 
was suspended in water to obtain particles with a cubic structure 
(defining the cubosomes). The formation of cubosomes was verified 
using cryo-TEM (Figs 2). The size of the particles in water was 
measured by dynamic light scattering and resulted in a size of 233±13 
nm. 
After in vitro characterisation, the cubosome powder was loaded into 
SU-8 microcontainers using a powder embossing method. Here, a 
shadow mask was aligned onto the cavity of the microcontainers (sitting 
on a silicon chip), and the microcontainers with the shadow mask were 
then pressed into the powder of cubosomes (Figs 3). This resulted in 
filled microcontainers, and this was verified using scanning electron 
microscope (SEM) and x-ray microtomography (Figs 4).  
After loading the microcontainers with the powders, a lid of the pH 
sensitive polymer Eudragit L100-55 was deposited on the cavity of the 
microcontainers by a spray coating system. This can protect the vaccine 
inside the microcontainers through the stomach and provide a release of 
the vaccine powder in the intestine. The vaccine-filled and coated 
microcontainers are currently being tested in mice to evaluate the in vivo 
effect of this oral vaccine delivery system.    
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Figure 1: SEM image 
of a SU-8 microcontainer  
 
Figure 2. Cryo-TEM image of a 




Figure 3. Drawing of the powder embossing method for loading of the 






Figure 4. Loading of the microcontainers with cubosomes. a): SEM 
image of the loaded microcontainers, and b) & c): x-ray 
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